These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3344760)

  • 21. Five-day continuous infusion of 5-fluorouracil and pulsed folinic acid in patients with metastatic colorectal carcinoma: an effective second-line regimen.
    Streit M; Jaehde U; Stremetzne S; Ridwelski K; Kerz H; Strohbach F; Hohenberger P; Zwiebel FM; Hebart H; Böthig R; Kairies M; Zillig D; Schuchmann S; Warnecke S; Thiel E; Kreuser ED
    Ann Oncol; 1997 Nov; 8(11):163-5. PubMed ID: 9426339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with pretreated gastroenteropancreatic well-differentiated endocrine carcinomas.
    Ducreux MP; Boige V; Leboulleux S; Malka D; Kergoat P; Dromain C; Elias D; de Baere T; Sabourin JC; Duvillard P; Lasser P; Schlumberger M; Baudin E
    Oncology; 2006; 70(2):134-40. PubMed ID: 16645326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous infusion 5-fluorouracil as first-line therapy for metastatic breast cancer.
    Chu L; Sutton LM; Peterson BL; Havlin KA; Winer EP
    J Infus Chemother; 1996; 6(4):211-6. PubMed ID: 9229318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I trial of low dose N-phosphonacetyl-L-aspartic acid and high dose 5-fluorouracil administered concomitantly with radiation therapy for unresectable localized adenocarcinoma of the pancreas.
    Ardalan B; Ucar A; Reddy R; Livingstone AS; Markoe A; Schwade J; Richman SP; Donofrio K
    Cancer; 1994 Oct; 74(7):1869-73. PubMed ID: 8082092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-dose continuous infusion 5-fluorouracil. Evaluation in advanced breast carcinoma.
    Huan S; Pazdur R; Singhakowinta A; Samal B; Vaitkevicius VK
    Cancer; 1989 Feb; 63(3):419-22. PubMed ID: 2912520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II clinical trial of parenteral hydroxyurea in combination with fluorouracil, interferon and filgrastim in the treatment of advanced pancreatic, gastric and neuroendocrine tumors.
    Kaubisch A; Kaleya R; Haynes H; Rozenblit A; Wadler S
    Cancer Chemother Pharmacol; 2004 Apr; 53(4):337-40. PubMed ID: 14704829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
    Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II trial of interleukin 2, interferon alpha, and 5-fluorouracil in metastatic renal cell cancer: a cytokine working group study.
    Dutcher JP; Logan T; Gordon M; Sosman J; Weiss G; Margolin K; Plasse T; Mier J; Lotze M; Clark J; Atkins M
    Clin Cancer Res; 2000 Sep; 6(9):3442-50. PubMed ID: 10999727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II trial of 7-day continuous 5-fluorouracil infusion in the treatment of advanced colorectal carcinoma.
    Rougier P; Ammarguellat H; Ghosn M; Piot G; Benhamed M; Tigaud JM; Laplaige P; Theodore C; Kac J; Goldberg J
    Oncology; 1992; 49(1):35-9. PubMed ID: 1542491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase II trial of weekly high dose continuous infusion 5-fluorouracil plus oral leucovorin in patients with advanced colorectal cancer. The Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD).
    Aranda E; Cervantes A; Dorta J; Blanco E; Fernández-Martos C; Cruz-Hernandez JJ; Carrato A; Gonzalez-Mancha R; García-Conde J; Díaz-Rubio E
    Cancer; 1995 Aug; 76(4):559-63. PubMed ID: 8625147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged continuous infusion of fluorouracil with weekly bolus leucovorin: a phase II study in patients with disseminated colorectal cancer.
    Leichman CG; Leichman L; Spears CP; Rosen PJ; Jeffers S; Groshen S
    J Natl Cancer Inst; 1993 Jan; 85(1):41-4. PubMed ID: 8416255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Second-line chemotherapy with a hybrid-alternating regimen of bolus 5FU modulated by methotrexate and infusional 5FU modulated by folinic acid in patients with metastatic colorectal cancer pretreated with 5FU. A phase 2 study.
    Carlomagno C; Lauria R; De Laurentiis M; Arpino G; Massarelli E; Ferrara C; Milano A; Vernaglia Lombardi A; Costanzo R; Catalano G; Bianco AR; De Placido S
    Oncology; 2002; 63(3):219-25. PubMed ID: 12381900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stability studies on admixtures of 5-fluorouracil with carboplatin and 5-fluorouracil with heparin for administration in continuous infusion regimens.
    Sewell GJ; Allsopp M; Collinson MP; Tyrrell C; Prentice AJ; Copplestone JA
    J Clin Pharm Ther; 1994 Apr; 19(2):127-33. PubMed ID: 8071393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiotherapy and continuous infusion 5-fluorouracil in patients with nonresectable pancreatic carcinoma.
    Boz G; De Paoli A; Innocente R; Rossi C; Tosolini G; Pederzoli P; Talamini R; Trovò MG
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):736-40. PubMed ID: 11597816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of colorectal cancer and other malignancies with continuous infusion of 5-fluorouracil.
    Barbounis VP; Kalofonos HP; Munro AJ; McKenzie CG; Sackier JM; Epenetos AA
    Anticancer Res; 1989; 9(1):33-9. PubMed ID: 2705753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous infusion fluorouracil/leucovorin and bolus mitomycin-C as a salvage regimen for patients with advanced colorectal cancer.
    Conti JA; Kemeny NE; Saltz LB; André AM; Grossano DD; Bertino JR
    Cancer; 1995 Feb; 75(3):769-74. PubMed ID: 7828126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase II trial of 5-fluorouracil and high-dose leucovorin in gastric carcinoma and a phase I trial of intraperitoneal 5-fluorouracil and leucovorin.
    Arbuck SG; Douglass HO; Trave F; Rustum YM
    NCI Monogr; 1987; (5):203-5. PubMed ID: 3501544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: a phase I Eastern Cooperative Oncology Group Trial.
    Whittington R; Neuberg D; Tester WJ; Benson AB; Haller DG
    J Clin Oncol; 1995 Jan; 13(1):227-32. PubMed ID: 7799024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II study of irinotecan, leucovorin, 5-fluorouracil and tegafur/uracil for metastatic colorectal cancer.
    Kono T; Ebisawa Y; Tomita I; Chisato N; Kamiya K; Asama T; Ayabe T; Ashida T; Kohgo Y; Kasai S
    J Chemother; 2005 Apr; 17(2):224-7. PubMed ID: 15920910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II trial of streptozotocin, mitomycin-C and 5-fluorouracil (SMF) in the treatment of advanced pancreatic cancer.
    Wiggans RG; Woolley PV; Macdonald JS; Smythe T; Ueno W; Schein PS
    Cancer; 1978 Feb; 41(2):387-91. PubMed ID: 147131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.